https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Heart-MS.jpg

Global Interventional Cardiology Market Size, Share & COVID19 Impact Analysis by Product (Coronary Atherectomy Devices, Catheters (IVUS, OCT, Diagnostic, Balloon, Interventional), Guidewires (Diagnostic, Interventional), Introducer Sheaths, Vascular Closure, Balloon-Inflation, and CEP devices) – Forecast to 2027

  • Year: 2021
  • Scope: 2021-2027
  • Region: Africa, Middle East, North America, Asia-Pacific, Europe, Latin America
  • Pages: 547
  • Published Date: 11/24/2020
  • Type: MedSuite

In 2020, the global interventional cardiology market size was valued at approximately $11.1 billion, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market size is expected to reach an astonishing $16.2 billion in 2027.

Over 40% of the global interventional cardiology market share was controlled by Boston Scientific, Abbott, and Medtronic. This global market research includes an analysis of 46 interventional cardiology companies spawning across more than 70 countries in the world.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Interventional Cardiology Procedure Volumes
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Market Drivers & Limiters for Each Global Interventional Cardiology market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Global Interventional Cardiology market
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

COVID19 Impact on the Global Interventional Cardiology Market

Due to COVID19, the global interventional cardiology market size decreased by 20% from 2019, reaching a valuation of $11.1 billion in 2020. The global market is expected to recover in early 2022 and continue growing at a steady pace.

The World Health Organization confirmed COVID-19 as a pandemic in March 2020. Since then, millions of patients around the world had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and lung conditions. As a result, every region around the world has experienced record low numbers for angiographies and angioplasties in 2020.

For instance, in Spain, angioplasty procedures were down 40% within the first week of the lockdown in April. There were also 48% fewer diagnostic examinations and 81% fewer transcatheter procedure interventions. Lombardy, one of Italy’s worst affected regions, shut down 80% of its cardiac surgical units in order to preserve resources for emergency COVID-related cases.

Global Interventional Cardiology Market Insights

Global technologies, such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed.

Global Interventional Cardiology Market Size by Segment, 2017-2027

Access to healthcare and overall hospital infrastructure in developing countries within Latin America and the Asia Pacific, such as China and India, have been increasing over the last decade. In Brazil, for example, healthcare access in the most remote and poorest areas of the country has been dramatically improved through their Family Health Program (PSF) initiative. Since this program launched in 1994, states in Brazil were required to allocate a minimum of 12% of the total budget to health, while municipal governments must spend 15% of their budget on health.

Global Interventional Cardiology Market Share Insight

In 2020, the global interventional cardiology market share was controlled by three key competitors – Boston Scientific, Abbott, and Medtronic.

Global Interventional Cardiology Market Share Leaders, 2017-2027

Boston Scientific was the leading competitor in the global market for interventional cardiology devices in 2020. The company was the market leader in coronary balloon catheters, coronary embolic protection devices, and coronary atherectomy devices markets. Boston Scientific offers the Maverick™, Apex™, and Emerge® PTCA devices, as well as the Flextome™ cutting balloon catheter.

Abbott was the second leading competitor in the global interventional cardiology market. The company held notable positions in the interventional coronary guidewire, coronary stent, FFR guidewire (within the diagnostic coronary catheter and guidewire market), and OCT catheter markets.

Medtronic was the third leading competitor in the global market in 2020. The company performed the strongest in the interventional coronary catheter market, where it offered the Launcher®, Sherpa NX™ Active, and Sherpa NX™ Balanced product lines under its portfolio.

Report Regional Coverage

Throughout this research series, iData Research has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Detailed Market Segmentation

While this MedSuite report contains all the Global Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

  • Coronary Stent Market – MedCore – The market is further broken down into segments by:
    • Device Type: Bare-Metal Stents, and Drug-Eluting Stents.
  • Coronary Balloon Catheter Market – MedCore – The market is also further segmented by:
    • Device Type: PTCA Balloon, Specialty Balloon, and Drug-Eluting Balloon catheters.
  • Balloon-Inflation Device Market – MedCore – In-depth analysis of the Balloon-Inflation Device market.
  • Interventional Coronary Catheter Market – MedCore – The interventional catheters are used to place devices, such as stents and balloons, and are analyzed on a unit-basis within this global report.
  • Interventional Coronary Guidewire Market – MedCore – Interventional guidewires are often the first device type to cross an arterial lesion, and they are analyzed in-depth within this market research.
  • Coronary Embolic Protection Device Market – MedCore – The research includes an in-depth analysis of the Coronary Embolic Protection Device market.
  • Coronary Atherectomy Device Market – MedCore – This market report includes an in-depth analysis of the intricate Coronary Atherectomy devices market.
  • Introducer Sheath Market – MedCore – This market report includes an in-depth analysis of the Introducer Sheath market.
  • Coronary Vascular Closure Device (VCD)  Market – MedCore – Development of both the peripheral and coronary markets for minimally invasive cardiovascular therapies created a market for post-procedural vascular closure devices (VCDs).
  • Diagnostic Coronary Catheter & Guidewire Market – MedCore – The chapter takes a closer look at the different market segments, including Diagnostic Catheter, Diagnostic Guidewire, and Fractional Flow Reserve Guidewire markets.
  • Coronary Intravascular Ultrasound (IVUS) Market – MedCore – This global market research takes a closer look at the fast-growing Coronary IVUS device market.
  • Coronary Optical Coherency Tomography Market – MedCore – In-depth analysis of the Coronary Optical Coherency Tomography market.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR THE GLOBAL INTERVENTIONAL CARDIOLOGY MARKET REPORT SUITE

TABLE OF CONTENTS I
LIST OF FIGURES XIV
LIST OF CHARTS XXV
EXECUTIVE SUMMARY 1
GLOBAL INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 11
MARKETS INCLUDED 12
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 17
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research 20
Step 5: Research Analysis: Establishing Baseline Estimates 22
Step 6: Market Forecast and Analysis 23
Step 7: Identify Strategic Opportunities 25
Step 8: Final Review and Market Release 26
Step 9: Customer Feedback and Market Monitoring 27

IMPACT OF COVID-19 ON THE GLOBAL INTERVENTIONAL CARDIOLOGY DEVICE MARKET

2.1 INTRODUCTION 28
2.2 COUNTRY PROFILE 30
2.2.1 North America 30
2.2.2 Latin America 30
2.2.3 Western Europe 31
2.2.4 Central & Eastern Europe 31
2.2.5 Asia-Pacific 32
2.2.6 Middle East 32
2.2.7 Africa 33
2.3 ANALYSIS BY MARKET SEGMENT 34
2.3.1 Best Case Scenario 34
2.3.2 Base Case Scenario 35
2.3.3 Worst Case Scenario 36

DISEASE OVERVIEW

3.1 BASIC ANATOMY 38
3.2 DISEASE TREATMENTS AND DIAGNOSTICS 40
3.2.1 General Diagnostics 40
3.2.2 Coronary Artery Disease (CAD) 40
3.2.3 Myocardial Infarction (MI) 41
3.2.4 Angina Pectoris 42
3.3 PATIENT DEMOGRAPHICS 43
3.3.1 General Statistics 43

PRODUCT ASSESSMENT

4.1 INTRODUCTION 45
4.2 PRODUCT PORTFOLIOS 45
4.2.1 Coronary Stent Market 45
4.2.2 Coronary Balloon Catheter Market 48
4.2.3 Balloon-Inflation Device Market 51
4.2.4 Interventional Coronary Catheter Market 52
4.2.5 Interventional Coronary Guidewire Market 55
4.2.6 Coronary Embolic Protection Device Market 58
4.2.6.1 Saphenous Vein Grafts 58
4.2.6.2 Protection Mechanism 58
4.2.6.2.1 Filter Basket 58
4.2.6.2.2 Distal Balloon Occlusion 59
4.2.7 Coronary Atherectomy Device Market 60
4.2.7.1 Laser Atherectomy 60
4.2.7.2 Directional Coronary Atherectomy (DCA) 60
4.2.7.3 Mechanical Atherectomy 61
4.2.8 Coronary Thrombectomy Device Market 62
4.2.9 Coronary Chronic Total Occlusion Device Market 63
4.2.10 Coronary Introducer Sheath Market 65
4.2.10.1 Femoral Approach 65
4.2.10.2 Radial/Brachial Approach 66
4.2.11 Coronary Vascular Closure Device Market 68
4.2.12 Diagnostic Coronary Catheter & Guidewire 70
4.2.13 Coronary Intravascular Ultrasound Market 72
4.2.14 Optical Coherence Tomography Market 74
4.2.15 Hemostasis Valve Market 76
4.3 REGULATORY ISSUES AND RECALLS 77
4.3.1 Abbott 77
4.3.1.1 Coronary Stent 77
4.3.1.2 Coronary Balloon Catheter 77
4.3.1.3 Introducer Sheath 79
4.3.1.4 Coronary Vascular Closure Device 79
4.3.2 Boston Scientific 80
4.3.2.1 Coronary Stent 80
4.3.2.2 Coronary Balloon Catheter 80
4.3.2.3 Balloon-Inflation Device 81
4.3.2.4 Interventional Coronary Catheter 81
4.3.2.5 Interventional Coronary Guidewire 82
4.3.2.6 Coronary Thrombectomy 83
4.3.3 Cardinal Health 84
4.3.3.1 Coronary Stent 84
4.3.4 Medtronic 85
4.3.4.1 Coronary Stent 85
4.3.4.2 Introducer Sheath 85
4.3.4.3 Coronary Balloon Catheter 86
4.3.4.4 Interventional Coronary Catheter 86
4.3.5 Merit Medical Systems 88
4.3.5.1 Introducer Sheath 88
4.3.7 Terumo 89
4.3.7.1 Interventional Coronary Catheter 89
4.3.7.2 Introducer Sheath 90
4.3.7.3 Coronary Vascular Closure Device 91
4.4 CLINICAL TRIALS 92
4.4.1 Coronary Stent 93
4.4.1.1 Abbott 93
4.4.1.2 Boston Scientific 94
4.4.1.3 Medtronic 95
4.4.2 Coronary Balloon Catheter 99
4.4.2.1 Boston Scientific 99
4.4.2.2 Medtronic 99
4.4.3 Balloon Inflation Device 100
4.4.3.1 Central Arkansas Veterans Healthcare System 100
4.4.3.2 Guy’s and St Thomas’ NHS Foundation Trust 100
4.4.4 Interventional Coronary Catheter 101
4.4.4.1 Medtronic 101
4.4.4.2 Philips 103
4.4.5 Coronary Embolic Protection Device 104
4.4.5.1 Icahan School of Medicine at Mount Sinai 104
4.4.5.2 Javelin Medical 104
4.4.5.3 Keystone Heart 105
4.4.5.4 Microvention-Terumo, Inc 106
4.4.6 Coronary Atherectomy Device 107
4.4.6.1 Segeberger Kliniken GmbH 107
4.4.6.2 Spectranetics Corporation 107
4.4.7 Coronary Vascular Closure Device 108
4.4.7.1 Cordis Corporation 108
4.4.7.2 Medtronic 109
4.4.7.3 Terumo Medical Corporation 109
4.4.8 Coronary Intravascular Ultrasound 110
4.4.8.1 Aarhhus University Hospital Skejby 110
4.4.8.2 European Cardiovascular Research Institute 111
4.4.9 Coronary Optical Coherence Tomography 112
4.4.9.1 Columbia University 112

GLOBAL INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

5.1 INTRODUCTION 113
5.1.1 Population at Risk 113
5.2 MARKET OVERVIEW 115
5.3 TREND ANALYSIS BY REGION 120
5.4 DRIVERS AND LIMITERS 123
5.4.1.1 Market Drivers 123
5.4.1.2 Market Limiters 125
5.5 COMPETITIVE MARKET SHARE ANALYSIS 128
5.6 MERGERS AND ACQUISITIONS 134
5.7 COMPANY PROFILES 136
5.7.1 Abbott 136
5.7.2 Asahi Intecc 138
5.7.3 Boston Scientific 139
5.7.4 Cardinal Health 140
5.7.4.1 Cordis (Cardinal Health) 141
5.7.5 Cardiovascular Systems Inc. 142
5.7.6 Cook Medical 143
5.7.7 Medtronic 144
5.7.8 Merit Medical Systems 146
5.7.9 Penumbra 147
5.7.10 Philips 148
5.7.11 Teleflex 150
5.7.12 Terumo 152
5.8 SWOT ANALYSIS 154
5.8.1 Abbott 155
5.8.2 Asahi Intecc 156
5.8.3 Boston Scientific 157
5.8.4 Cardinal Health 158
5.8.5 Cardiovascular Systems Inc. 159
5.8.6 Cook Medical 160
5.8.7 Medtronic 161
5.8.8 Merit Medical Systems 162
5.8.9 Penumbra 163
5.8.10 Philips 164
5.8.11 Teleflex 165
5.8.12 Terumo 166

PROCEDURE NUMBERS

6.1 INTRODUCTION 167
6.2 PROCEDURES 170
6.2.1.1 Angiography Procedures 170
6.2.1.2 Angioplasty Procedures 170
6.2.1.3 Coronary Atherectomy Procedures 170
6.2.1.4 Catheterization Procedures 171
6.2.2 Global Procedures 172
6.2.3 North America Procedures 174
6.2.4 Latin America Procedures 176
6.2.5 Western Europe Procedures 178
6.2.6 Central & Eastern Europe Procedures 180
6.2.7 Middle East Procedures 182
6.2.8 Asia-Pacific Procedures 184
6.2.9 Africa Procedures 186

NORTH AMERICA MARKET

7.1 INTRODUCTION 188
7.1.1 Population at Risk 188
7.1.2 Countries Included 189
7.2 MARKET OVERVIEW 190
7.3 MARKET ANALYSIS AND FORECAST 196
7.3.1 Coronary Stent Market 196
7.3.1.1 Total Coronary Stent Market 199
7.3.1.1.1 Bare-Metal Stent Market 200
7.3.1.1.2 Drug-Eluting Stent Market 201
7.3.2 Coronary Balloon Catheter Market 202
7.3.2.1 Total Coronary Balloon Catheter Market 204
7.3.2.1.1 PTCA Balloon Catheter Market 205
7.3.2.1.2 Drug-Eluting Balloon Catheter Market 206
7.3.2.1.3 Specialty Balloon Catheter Market 207
7.3.3 Balloon-Inflation Device Market 208
7.3.4 Interventional Coronary Catheter Market 210
7.3.5 Interventional Coronary Guidewire Market 212
7.3.6 Coronary Embolic Protection Device Market 215
7.3.7 Coronary Atherectomy Device Market 218
7.3.8 Introducer Sheath Market 221
7.3.9 Coronary Vascular Closure Device Market 224
7.3.10 Diagnostic Coronary Catheter & Guidewire Market 226
7.3.10.1.1 Diagnostic Coronary Catheter Market 229
7.3.10.1.2 Diagnostic Coronary Guidewire Market 230
7.3.10.1.3 Fractional Flow Reserve Guidewire Market 231
7.3.11 Coronary Intravascular Ultrasound Catheter Market 232
7.3.12 Coronary Optical Coherence Tomography Catheter Market 235

LATIN AMERICA MARKET

8.1 INTRODUCTION 237
8.1.1 Population at Risk 237
8.1.2 Countries Included 238
8.2 MARKET OVERVIEW 239
8.3 MARKET ANALYSIS AND FORECAST 245
8.3.1 Coronary Stent Market 245
8.3.1.1 Total Coronary Stent Market 248
8.3.1.1.1 Bare-Metal Stent Market 249
8.3.1.1.2 Drug-Eluting Stent Market 250
8.3.2 Coronary Balloon Catheter Market 251
8.3.2.1 Total Coronary Balloon Catheter Market 253
8.3.2.1.1 PTCA Balloon Catheter Market 254
8.3.2.1.2 Drug-Eluting Balloon Catheter Market 255
8.3.2.1.3 Specialty Balloon Catheter Market 256
8.3.3 Balloon-Inflation Device Market 257
8.3.4 Interventional Coronary Catheter Market 260
8.3.5 Interventional Coronary Guidewire Market 262
8.3.6 Coronary Embolic Protection Device Market 265
8.3.7 Coronary Atherectomy Device Market 268
8.3.8 Introducer Sheath Market 271
8.3.9 Coronary Vascular Closure Device Market 274
8.3.10 Diagnostic Coronary Catheter & Guidewire Market 277
8.3.10.1.1 Diagnostic Coronary Catheter Market 280
8.3.10.1.2 Diagnostic Coronary Guidewire Market 281
8.3.10.1.3 Fractional Flow Reserve Guidewire Market 282
8.3.11 Coronary Intravascular Ultrasound Catheter Market 283
8.3.12 Coronary Optical Coherence Tomography Catheter Market 286

For a Full Table of Contents, please contact iData.
The Interventional Cardiology Market Report Suite| Global | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Aachen Scientific
  • Abbott
  • ACIST
  • Acrostak
  • Advanced Vascular Dynamics
  • AngioDynamics
  • Argon Medical
  • Asahi Intecc
  • B. Braun
  • Baylis Medical
  • Becton Dickinson
  • Biolife
  • Biosensors International
  • Biotronik
  • Boston Scientific
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Cardiva Medical
  • CeloNova
  • Clearstream Technologies
  • Control Medical Technology
  • Cook Medical
  • DISA Medinotec
  • Galt Medical
  • Getinge
  • ICU Medical
  • Infraredx
  • InnoTherapy
  • Medtronic
  • Merit Medical
  • Morris Innovative
  • Opsens Medical
  • Oscor
  • PediaVascular
  • Philips
  • Reflow Medical
  • Rontis
  • Semier Technologies
  • Teleflex
  • Terumo
  • Tricol Biomedical
  • Tryton Medical
  • TZ Medical
  • US Endovascular
  • Vivasure
  • Z-Medica
One of the most accurate methods of market research in the medical device industry is to analyze the procedure volumes and trends. Through this study on the global interventional cardiology devices, iData Research has performed an analysis on the following procedure segments in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range.

Global Interventional Cardiology Procedure Volumes

Global Interventional Cardiology Procedure Volume Analysis

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology